Академический Документы
Профессиональный Документы
Культура Документы
FIRST APPROACH
SECOND APPROACH
APPROACH
Ideal Target
Third Approach
Year
1
2
margin $24,8 3
Second Supply Full Cycle Total
4
$5,551,207.20 $1,110,241.44 $15,913,460.64 5
$8,326,810.80 $1,665,362.16 $23,870,190.96
$11,102,414.40 $2,220,482.88 $31,826,921.28
$13,878,018.00 $2,775,603.60 $39,783,651.60
$16,653,621.60 $3,330,724.32 $47,740,381.92 Third Approach
Year
Total $159,134,606.40
ROI -62.49% 1
2
argin $58,13 3
APPROACH
lusion : Choose the second approach with Retail Price $125 which have gross margin $74,8, Pricing was done in such a
ner, so the company is not only able to achieve the desire ROI but also is able to capture a larger market base, The advantages
oosing The second approach with Retail Price $125 is Moderate market penetration, Moderate consumer awareness, Price
e Alli, and premium factoring Prescription drug with FDA. Beside that the second approach have disadvantages is chance the
ng out on getting maximum price. In the second approach, Metabical can focus on individuals who were immediately willing
to the health care providersfor a prescription.
Total
$55,026,240.00
$64,197,280.00
$73,368,320.00
$82,539,360.00
$91,710,400.00
$366,841,600.00
-14%
Total
$128,978,844.00
$150,475,318.00
$171,971,792.00
$193,468,266.00
$214,964,740.00
$859,858,960.00
103%
Total
$165,966,240.00
$193,627,280.00
$221,288,320.00
$248,949,360.00
$276,610,400.00
$1,106,441,600.00
161%